NEW YORK – OpGen announced Thursday that its subsidiary Curetis has received CE marking for its SARS-CoV-2 Kit with PULB.
The company is launching the kit in Europe.
The RT-PCR kit qualitatively detects the virus from oropharyngeal and nasopharyngeal swabs and works with isolated RNA or swabs treated with PCR-Compatible Universal Lysis Buffer, or PULB, which is provided in the kit. Offering PULB allows labs to bypass the need for extraction equipment and reagents, OpGen said.